Historical Stock Price
ACET historical stock prices picture
Adicet Bio (ACET) has the following price history information. Looking back at ACET historical stock prices for the last five trading days, on August 08, 2022, ACET opened at $18.88, traded as high as $19.25 and as low as $17.88, and closed at $18.15. Trading volume was a total of 411.00K shares. On August 09, 2022, ACET opened at $17.83, traded as high as $17.83 and as low as $16.70, and closed at $17.23. Trading volume was a total of 3.10M shares. On August 10, 2022, ACET opened at $17.20, traded as high as $18.32 and as low as $16.42, and closed at $16.58. Trading volume was a total of 309.20K shares. On August 11, 2022, ACET opened at $16.62, traded as high as $16.85 and as low as $15.53, and closed at $15.67. Trading volume was a total of 410.50K shares. On August 12, 2022, ACET opened at $15.55, traded as high as $16.41 and as low as $15.23, and closed at $15.40. Trading volume was a total of 450.00K shares.

ACET Historical Stock Prices By Date:

ACET historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adicet Bio shares, starting with a $10,000 purchase of ACET, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/29/2018
End date: 08/12/2022
Start price/share: $113.61
End price/share: $15.40
Dividends collected/share: $0.00
Total return: -86.44%
Average Annual Total Return: -35.64%
Starting investment: $10,000.00
Ending investment: $1,355.87
Years: 4.53
Date Open High Low Close Volume
08/08/2022 $18.88 $19.25 $17.88 $18.15 411.00K
08/09/2022 $17.83 $17.83 $16.70 $17.23 3.10M
08/10/2022 $17.20 $18.32 $16.42 $16.58 309.20K
08/11/2022 $16.62 $16.85 $15.53 $15.67 410.50K
08/12/2022 $15.55 $16.41 $15.23 $15.40 450.00K
Adicet Bio is a biopharmaceutical company discovering and developing allogeneic gamma delta T cell therapies for cancer. Co.'s product candidate, ADI-001, an allogeneic gamma delta T cell therapy expressing a chimeric antigen receptors (CAR) targeting CD20, is in Phase 1 study for the treatment of Non-Hodgkin's Lymphoma. Co.'s pipeline also includes ADI-002, an allogeneic gamma delta CAR-T cell therapy expressing a GPC3-targeted CAR and a cell intrinsic soluble form of interluiken-15, for the treatment of solid tumors. In addition, Co. is engaged in preclinical stage activities directed to expansion of its pipeline of product candidates for both hematological malignancies and solid tumors.
Date Close
08/08/2022$18.15
08/09/2022$17.23
08/10/2022$16.58
08/11/2022$15.67
08/12/2022$15.40
ACET is categorized under the Healthcare sector; below are some other companies in the same sector:

ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices
ACUR Historical Stock Prices
ACXP Historical Stock Prices
ADGI Historical Stock Prices

Also explore: ACET shares outstanding history

Email EnvelopeFree ACET Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ACET Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.